# Use of Biodesign® Otologic Graft in Tympanoplasty

> **NCT03904316** · PHASE4 · WITHDRAWN · sponsor: **Henry Ford Health System**

## Conditions studied

- Tympanic Membrane Perforation

## Interventions

- **BIOLOGICAL:** Biodesign Otologic graft
- **OTHER:** Autologous temporalis fascia

## Key facts

- **NCT ID:** NCT03904316
- **Lead sponsor:** Henry Ford Health System
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-10-03
- **Primary completion:** 2022-07-01
- **Final completion:** 2022-07-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The trial was stopped as the benefit was challenging to determine in preliminary usage.
- **Last updated:** 2025-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03904316

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03904316, "Use of Biodesign® Otologic Graft in Tympanoplasty". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03904316. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*